Risk of Dementia Diagnosis After Injurious Falls in Older Adults
On Sept. 30, 2024, a research team reported that emerging evidence suggested that mild cognitive impairment, which is…
Biology | Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Neurology | Non-Profit Research | Therapeutics
landmark UT Health San Antonio study found genetic risk-factor overlap between Alzheimer’s disease, and dementias
On Sept. 17, 2024, in landmark research, scientists at The University of Texas Health Science Center at San…
“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
Diagnostics | Disease | Life Science News | Medical Device | Nanotechnology | Neurology | Non-Profit Research | Therapeutics
Imaging technique shows new details of peptide structures
On Apr. 26, 2024, engineers at Washington University in St. Louis announced a new imaging technique that give…
Blood test for Alzheimer’s highly accurate in large, international study
On Feb. 22, 2022, Washington University in St. Louis announced that a blood test developed at the University’s…
NIH unveiled new online tool to improve Alzheimer’s clinical trials recruitment
On Jul. 29, 2021, the National Institutes of Health announced it had launched a new online research tool…
Eisai and Biogen announced FDA granted Breakthrough Therapy Designation for Lecanemab for treatment of Alzheimer’s disease
On Jun. 23, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
Seattle researchers teamed up to build hi-res brain map of Alzheimer’s disease
On Jun. 25, 2020, the Allen Institute announced a new a new $40.5 million collaborative research center in…
Alzheimerﾒs trial screening data links high amyloid levels with early stage disease
On Apr. 6, 2020, the first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) study…
Research on brain structure highlighted cells linked to Alzheimer’s and autism
On Mar. 16, 2020, new insights into the architecture of the brain were revealed by scientists at the…
Biotechnology | Diagnostics | Life Science News | Neurology | NIH | Non-Profit Research | Therapeutics
Emory Selected to lead international drug discovery center for Alzheimer’s
On Oct 1, 2019, the National Institute on Aging (NIA) announced it had awarded approximately $37 million over…
Penn researcher Virginia MY Lee, PhD, received $3 million Breakthrough Prize
On Sept. 5, 2019, Penn Professor Virginia M.Y. Lee, PhD received the Breakthrough Prize in Life Sciences, in…
A UCLA-led research team identified genetic processes involved in the neurodegeneration that occurs in dementiaﾠ
On Dec 3, 2018, a University of California, Los Angeles (UCLA) led research team announced they had identified…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
Emory renamed its Alzheimer’s Disease Research Center the Goizueta Alzheimer’s Disease Research Center
On Aug. 24, 2018, Emory Universityﾒs Alzheimer’s Disease Research Center was renamed the Goizueta Alzheimer’s Disease Research Center,…
Canada Foundation awarded $6 million for Innovation Metabolomics Innovation Centre at the University of Alberta
On Jan. 9, 2017, the Canada Foundation for Innovation (CFI) awarded $6 million for Canada’s national metabolomics laboratory,…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
The Kavli Foundation awarded $20 million to establish the Kavli Neural Systems Institute at The University of California, San Francisco
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Institute for Fundamental…
Biotechnology | Diagnostics | Life Science News | Medical Device | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics
Keck School of Medicine of USC established USC Alzheimer’s Therapeutic Research Institute
On Jun. 26, 2015, The Keck School of Medicine announced it had established the University of Southern California…
Canadian diamond pioneer Charles Fipke donated $9.1 million for Alzheimer’s research at UBC
On Sept. 30, 2014, Canadian diamond pioneer Charles Fipke donated $9.1 million for Alzheimer’s research at the University…
Largest international study of Alzheimer’s genes was published
On Oct. 28, 2013, Columbia University Medical Center announced publication of a Meta-analysis of 74,046 individuals that identified…
Roskamp Institute selected for funding by European Commission for a large-scale clinical trial on Nilvadipine
On May 25, 2011, the Roskamp Institute and an international research consortium led by Trinity College Dublin, were…
First international collaboration on Alzheimer’s disease genetics was launched
On Jan. 31, 2011, the first international collaboration on Alzheimer’s disease genetics was launched. The International Genomics of…
Texas Biomed geneticists announced discovery that a particular gene, VNN1, plays a major role in the regulation of HDL cholesterol levels
In 2007, Texas Biomed geneticists announced their discovery that a particular gene, VNN1, plays a major role in…
The Allen Institute for Brain Science Completed the Brain Atlas
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
Capillary Electrophoresis DNA Sequencer device was developed at Iowa State University
In 2000, the Capillary electrophoresis DNA sequencer device was developed by Dr. Edward Yeung at Iowa State University….
Peter St George-Hyslop developed a vaccine that prevented Alzheimer’s disease in mice. He and his team also discovered the nicastrin protein
In 2000, Dr. Peter St George-Hyslop developed a vaccine that prevented Alzheimer’s disease in mice. He and his…
The first genetically engineered mouse model showing amyloid plaques developed at the University of Minnesota
In 1996, the first genetically engineered mouse model showing amyloid plaques and dysfunctional learning and memory found in…
Dr. Judes Poirier discovered that apolipoprotein E is a genetic risk factor for Alzheimer’s disease
On Sept. 18, 1993, Dr. Judes Poirier discovered that apolipoprotein E was a genetic risk factor for Alzheimer’s…
Drs. Patrick and Edith McGeer developed the groundbreaking concept that inflammation plays a role in the pathology of Alzheimer’s disease
In 1987, Drs. Patrick and Edith McGeer developed the groundbreaking concept that inflammation plays a role in the…
University of Iowa research team determined precise areas of brain damage responsible for memory loss associated with Alzheimer’s disease
On Jan. 1, 1984, a University of Iowa College of Medicine research team headed by Dr. Antonio Damasio…
National Alzheimer’s Disease Month was established
On Nov. 30, 1983, the National Alzheimer’s Disease Month was established by former President Ronald Reagan. During each…